Regular follow-up appointments are essential for monitoring both therapeutic response and adverse effects
Location: Plainsboro, New JerseyWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Wegovy (semaglutide) injection, for subcutaneous use, Ozempic (semaglutide) injection, for subcutaneous use, and Victoza (liraglutide) injection, for subcutaneous use.FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Novo Nordisk promoted Wegovy, Ozempic, and Victoza in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner
What is the statute of limitations for filing a Trulicity lawsuit
How is semaglutide made and why does it matter
After first use The first time you puncture the rubber stopper with a needle, you introduce another variable: potential contamination
Currently, research into Ozempic discontinuation is limited, but some suggest that rebound hunger will be much stronger if the drug is stopped abruptly, rather than slowly tapered